Φορτώνει......
uPAR antibody (huATN-658) and Zometa reduce breast cancer growth and skeletal lesions
Urokinase plasminogen activator receptor (uPAR) is implicated in tumor growth and metastasis due to its ability to activate latent growth factors, proteases, and different oncogenic signaling pathways upon binding to different ligands. Elevated uPAR expression is correlated with the increased aggres...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Bone Res |
|---|---|
| Κύριοι συγγραφείς: | , , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
Nature Publishing Group UK
2020
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7165173/ https://ncbi.nlm.nih.gov/pubmed/32337090 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41413-020-0094-3 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|